Please join us for our next APP R&R: Read and Relax session where we will be discussing the ENGOT-cx11/GOG-3047/KEYNOTE-A18 trial data and the addition of pembrolizumab to chemo/RT in high risk, locally advanced cervical cancer. We recommend reviewing the paper prior to attending, but you may join even if you have not had a chance to read it. We look forward to chatting with you!

The APP R&R: Read and Relax series was developed by the SGO APP Committee and is meant to be an informal opportunity for APPs and other allied health professionals working directly in gyn onc patient care to get together virtually to connect and learn from one another in a casual, relaxed environment.